tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

HALO Stock Latest News

Halozyme sees FY26 EPS $7.75-$8.25, consensus $8.21
The FlyHalozyme sees FY26 EPS $7.75-$8.25, consensus $8.21
8d ago
HALO
Halozyme raises FY25 revenue view to $1.39B-$1.4B from $1.3B-$1.38B
PremiumThe Fly
Halozyme raises FY25 revenue view to $1.39B-$1.4B from $1.3B-$1.38B
8d ago
HALO
Leerink views ‘major deal’ on Entyvio as positive for Halozyme
PremiumThe Fly
Leerink views ‘major deal’ on Entyvio as positive for Halozyme
28d ago
TAK
HALO
Halozyme: ENHANZE Platform Partnerships in Immunology and Obesity Drive Underappreciated Royalty Upside and Support Buy Rating
PremiumRatings
Halozyme: ENHANZE Platform Partnerships in Immunology and Obesity Drive Underappreciated Royalty Upside and Support Buy Rating
28d ago
HALO
Halozyme price target raised to $90 from $79 at TD Cowen
PremiumThe Fly
Halozyme price target raised to $90 from $79 at TD Cowen
28d ago
HALO
Halozyme announces global collaboration, license agreement with Takeda
PremiumThe FlyHalozyme announces global collaboration, license agreement with Takeda
28d ago
TAK
HALO
Halozyme price target lowered to $75 from $79 at Morgan Stanley
Premium
The Fly
Halozyme price target lowered to $75 from $79 at Morgan Stanley
28d ago
HALO
CoreWeave initiated, Shopify downgraded: Wall Street’s top analyst calls
Premium
The Fly
CoreWeave initiated, Shopify downgraded: Wall Street’s top analyst calls
1M ago
ACN
CVX
Skye Bioscience, Halozyme enter collaboration, license agreement
PremiumThe Fly
Skye Bioscience, Halozyme enter collaboration, license agreement
1M ago
HALO
SKYE
Halozyme, Skye Bioscience announce global collaboration, license agreement
PremiumThe Fly
Halozyme, Skye Bioscience announce global collaboration, license agreement
1M ago
HALO
SKYE
Rybrevant FASPRO Approval and ENHANZE Royalties Reset Halozyme’s Long-Term Growth Outlook, Supporting a Buy Rating and $90 Target
PremiumRatings
Rybrevant FASPRO Approval and ENHANZE Royalties Reset Halozyme’s Long-Term Growth Outlook, Supporting a Buy Rating and $90 Target
2M ago
HALO
Johnson and Johnson’s Rybrevant Faspro combination in NSCLC approved by FDA
PremiumThe Fly
Johnson and Johnson’s Rybrevant Faspro combination in NSCLC approved by FDA
2M ago
JNJ
HALO
Halozyme Approves Stock Grant for CEO Incentive
PremiumCompany AnnouncementsHalozyme Approves Stock Grant for CEO Incentive
2M ago
8K
HALO
Halozyme Elects James Lang to Board of Directors
Premium
Company Announcements
Halozyme Elects James Lang to Board of Directors
2M ago
8K
HALO
Buy/Sell: Wall Street’s top 10 stock calls this week
Premium
The Fly
Buy/Sell: Wall Street’s top 10 stock calls this week
2M ago
DG
PD
Halozyme wins preliminary injunction against Merck’s Keytruda SC in Germany
PremiumThe Fly
Halozyme wins preliminary injunction against Merck’s Keytruda SC in Germany
2M ago
MRK
HALO
Toast upgraded, PayPal downgraded: Wall Street’s top analyst calls
PremiumThe Fly
Toast upgraded, PayPal downgraded: Wall Street’s top analyst calls
2M ago
GE
AAL
Halozyme downgraded to Sell from Neutral at Goldman Sachs
PremiumThe Fly
Halozyme downgraded to Sell from Neutral at Goldman Sachs
2M ago
HALO
Strategic Acquisition and FDA Approval Bolster Halozyme’s Market Position with a Buy Rating
PremiumRatings
Strategic Acquisition and FDA Approval Bolster Halozyme’s Market Position with a Buy Rating
2M ago
HALO
Halozyme Announces CFO Transition Plan
PremiumCompany AnnouncementsHalozyme Announces CFO Transition Plan
2M ago
8K
HALO
Strategic Importance of Halozyme’s ENHANZE Platform and Its Growth Potential in Subcutaneous Drug Delivery
Premium
Ratings
Strategic Importance of Halozyme’s ENHANZE Platform and Its Growth Potential in Subcutaneous Drug Delivery
3M ago
HALO
Halozyme price target raised to $56 from $54 at Goldman Sachs
Premium
The Fly
Halozyme price target raised to $56 from $54 at Goldman Sachs
3M ago
HALO

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >